• About
  • Approach
  • Pipeline
  • Beyond
  • Publications
  • Investor
  • Careers + Culture
Press

Press Release

A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Toxin Conjugate) given intravenously in patients with advanced solid tumours

Press
10.01.2018

Recommended Press Releases

Press
07.12.2022

Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT7480 Program in the Journal of Medicinal Chemistry

Press
07.12.2022

Bicycle Therapeutics Announces Further Expansion of Genentech Immuno-Oncology Collaboration

Press
06.08.2022

Bicycle Therapeutics Announces First Patient Dosed in Expansion Cohorts of Phase I/II Trial of Bicycle® Toxin Conjugate BT5528 in...

Press
Close
United Kingdom

Blocks A & B Portway Building
Granta Park
Great Abington
Cambridge CB21 6GS

View Google Map
United States

35 Cambridgepark Drive
Cambridge, MA
02140

View Google Map
General Enquiries
info@bicycletx.com
Follow
LinkedIn
Twitter
Privacy
© Bicycle Therapeutics 2022
Candidate Privacy
Designed by Greenspace
Sign up

Search

Close Search
Hello

We use cookies and other technologies to optimise your experience and analyse our traffic. Please confirm you are happy to accept. You can change your preferences in “Cookie Settings”.

Find out more
Accept